Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 6/27/2025 | 3/28/2025 | 12/27/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $7,698 | $7,504 |
| - Cash | $702 | $699 | $750 | $612 |
| + Debt | $28 | $28 | $40 | $44 |
| Enterprise Value | – | – | $6,988 | $6,937 |
| Revenue | $307 | $316 | $370 | $357 |
| % Growth | -2.7% | -14.6% | 3.5% | – |
| Gross Profit | $268 | $272 | $334 | $316 |
| % Margin | 87.1% | 86.1% | 90.3% | 88.6% |
| EBITDA | $60 | $71 | $145 | $111 |
| % Margin | 19.7% | 22.7% | 39.1% | 31.2% |
| Net Income | $49 | $46 | $92 | $68 |
| % Margin | 16.1% | 14.6% | 24.8% | 19% |
| EPS Diluted | 0.51 | 0.48 | 0.94 | 0.7 |
| % Growth | 6.3% | -48.9% | 34.3% | – |
| Operating Cash Flow | $123 | $68 | $175 | $107 |
| Capital Expenditures | -$22 | -$6 | -$7 | -$7 |
| Free Cash Flow | $101 | $61 | $168 | $100 |